Central Nervous System Agents in Medicinal Chemistry
Title:Meet Our Associate Board Member
Volume: 20 Issue: 1
Author(s): Majid Asadi-Shekaari
Affiliation:
Export Options
About this article
Cite this article as:
Asadi-Shekaari Majid, Meet Our Associate Board Member, Central Nervous System Agents in Medicinal Chemistry 2020; 20 (1) . https://dx.doi.org/10.2174/187152492001200303164412
DOI https://dx.doi.org/10.2174/187152492001200303164412 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Marine Algae of the Genus Gracilaria as Multi Products Source for Different Biotechnological and Medical Applications
Recent Patents on Biotechnology Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil)
Current Drug Delivery Triphenyl Phosphite-mediated “Green” Synthesis of Novel Carboxycoumarin Amides
Current Green Chemistry Biomarkers of Oxidative Stress in the Assessment of Enantioselective Toxicity of Chiral Pesticides
Current Protein & Peptide Science Improving Cognitive Outcome in Cerebral Malaria: Insights from Clinical and Experimental Research
Central Nervous System Agents in Medicinal Chemistry Cellular Mechanisms Underlying the Interaction between Cannabinoid and Opioid System
Current Drug Targets Development of Crystalline Cellulosic Fibres for Sustained Release of Drug
Current Topics in Medicinal Chemistry GABAergic and Endocannabinoid Dysfunction in Anxiety - Future Therapeutic Targets?
Current Pharmaceutical Design Optimal Sedation for the Ventilation of Critically Ill Patients
Current Respiratory Medicine Reviews ERRATUM
Current Neuropharmacology The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies
Current Neuropharmacology Postoperative COVID-19 Pneumonia in an Asymptomatic Patient: A Case Report
Infectious Disorders - Drug Targets Pharmacokinetic Study of Four Components in Rat Plasma After Oral Administration of Guanmaitong Granule by UPLC-MS/MS
Current Pharmaceutical Analysis NF-κB Down–regulation and PARP Cleavage by novel 3-α-butyryloxy-β-boswellic Acid Results in Cancer Cell Specific Apoptosis and in vivo Tumor Regression
Anti-Cancer Agents in Medicinal Chemistry Prolyl Oligopeptidase: A Rising Star on the Stage of Neuroinflammation Research
CNS & Neurological Disorders - Drug Targets Detection and Treatment of Alcohol-Induced Hypertension
Current Hypertension Reviews Daclizumab: A Potential Asthma Therapy?
Recent Patents on Inflammation & Allergy Drug Discovery COPD Evaluation: Beyond the Airway Obstruction, a Follow Up
Current Respiratory Medicine Reviews Lessons from Seven Decades of Antituberculosis Drug Discovery
Current Topics in Medicinal Chemistry